Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerA novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
PeerPaul Hunter, MD
PeerChallenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
PeerWhat do we know now that could have changed the history of CETP inhibition?: genetics and biology
John Kastelein, MD, PhD
PeerImproving Adherence to CRC Screening: A Primary Care Physician’s Guide
Paul Hunter, MD
PeerThe Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
Manish A. Shah, MD FASCO
PeerDigesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Engaging Patients and Caregivers About Digital Therapeutics
Artificial Intelligence in Medicine: 5 Key Issues Physicians Are Facing
The Expansion of Telemedicine: How It’s Impacting Rural and Underserved Communities
How Artificial Intelligence Can Predict and Prevent the Next Pandemic
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
PeerAnton P. Porsteinsson, MD
PeerThe Burden of TED
Dry Eye Disease Assessment and Treatment Plans
Christopher Starr, MD, FACS
PeerTailored to Fit: Precision Medicine in Metastatic CRC
Exploring the Risk of HF Hospitalization or CV Death in HFrEF Patients and a Potential Treatment Option
Javed Butler, MD, MPH, FACC, FAHA
PeerMAC Lung Disease: Considerations in Initiating Treatment
Expert Insights and Clinical Strategies for Postpartum Depression Screening
Navigating mCRC: A Closer Look at Biomarker Testing